Cargando…
Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients
BACKGROUND: Hypercalcemia of malignancy (HCM) is a serious metabolic complication, and the highest rates are in multiple myeloma (MM). The cause of hypercalcemia in newly diagnosed multiple myeloma (NDMM) remains unknown. We sought to evaluate the prognostic impact and mechanism of hypercalcemia in...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724491/ https://www.ncbi.nlm.nih.gov/pubmed/33145966 http://dx.doi.org/10.1002/cam4.3594 |
_version_ | 1783620549415534592 |
---|---|
author | Bao, Li Wang, Yutong Lu, Minqiu Chu, Bin Shi, Lei Gao, Shan Fang, Lijuan Xiang, Qiuqing |
author_facet | Bao, Li Wang, Yutong Lu, Minqiu Chu, Bin Shi, Lei Gao, Shan Fang, Lijuan Xiang, Qiuqing |
author_sort | Bao, Li |
collection | PubMed |
description | BACKGROUND: Hypercalcemia of malignancy (HCM) is a serious metabolic complication, and the highest rates are in multiple myeloma (MM). The cause of hypercalcemia in newly diagnosed multiple myeloma (NDMM) remains unknown. We sought to evaluate the prognostic impact and mechanism of hypercalcemia in patients with symptomatic NDMM. METHODS: We studied all consecutive MM patients who were initially diagnosed and followed up at Beijing Jishuitan Hospital between February 2013 and December 2019; 357 patients were included in the retrospective analysis. RESULTS: A total of 16.8% of MM patients presented with hypercalcemia at the time of MM diagnosis. The presence of hypercalcemia was associated with higher serum levels of β2 microglobulin, creatinine, phosphorus, uric acid, procollagen I N‐terminal peptide, β‐carboxy‐terminal cross‐linking telopeptide of type I collagen and osteocalcin, lower serum levels of hemoglobin, parathyroid hormone (PTH), and advanced ISS and R‐ISS stages. Multivariate analysis showed that serum PTH, hemoglobin, creatinine, and uric acid levels were the main factors affecting hypercalcemia. The presence of hypercalcemia was associated with significantly inferior survival (40 months vs 57 months, p < 0.05) based on univariate analysis, and it remained an independent poor prognostic factor (HR: 1.854, 95% CI: 1.006‐3.415, adjusted p = 0.048) in a multivariate model that included age and R‐ISS stage. CONCLUSION: This study shows that hypercalcemia is associated with poor survival and is caused by manifold factors with humoral effects and local bone destruction. |
format | Online Article Text |
id | pubmed-7724491 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77244912020-12-13 Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients Bao, Li Wang, Yutong Lu, Minqiu Chu, Bin Shi, Lei Gao, Shan Fang, Lijuan Xiang, Qiuqing Cancer Med Clinical Cancer Research BACKGROUND: Hypercalcemia of malignancy (HCM) is a serious metabolic complication, and the highest rates are in multiple myeloma (MM). The cause of hypercalcemia in newly diagnosed multiple myeloma (NDMM) remains unknown. We sought to evaluate the prognostic impact and mechanism of hypercalcemia in patients with symptomatic NDMM. METHODS: We studied all consecutive MM patients who were initially diagnosed and followed up at Beijing Jishuitan Hospital between February 2013 and December 2019; 357 patients were included in the retrospective analysis. RESULTS: A total of 16.8% of MM patients presented with hypercalcemia at the time of MM diagnosis. The presence of hypercalcemia was associated with higher serum levels of β2 microglobulin, creatinine, phosphorus, uric acid, procollagen I N‐terminal peptide, β‐carboxy‐terminal cross‐linking telopeptide of type I collagen and osteocalcin, lower serum levels of hemoglobin, parathyroid hormone (PTH), and advanced ISS and R‐ISS stages. Multivariate analysis showed that serum PTH, hemoglobin, creatinine, and uric acid levels were the main factors affecting hypercalcemia. The presence of hypercalcemia was associated with significantly inferior survival (40 months vs 57 months, p < 0.05) based on univariate analysis, and it remained an independent poor prognostic factor (HR: 1.854, 95% CI: 1.006‐3.415, adjusted p = 0.048) in a multivariate model that included age and R‐ISS stage. CONCLUSION: This study shows that hypercalcemia is associated with poor survival and is caused by manifold factors with humoral effects and local bone destruction. John Wiley and Sons Inc. 2020-11-04 /pmc/articles/PMC7724491/ /pubmed/33145966 http://dx.doi.org/10.1002/cam4.3594 Text en © 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Cancer Research Bao, Li Wang, Yutong Lu, Minqiu Chu, Bin Shi, Lei Gao, Shan Fang, Lijuan Xiang, Qiuqing Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients |
title | Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients |
title_full | Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients |
title_fullStr | Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients |
title_full_unstemmed | Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients |
title_short | Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients |
title_sort | hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients |
topic | Clinical Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724491/ https://www.ncbi.nlm.nih.gov/pubmed/33145966 http://dx.doi.org/10.1002/cam4.3594 |
work_keys_str_mv | AT baoli hypercalcemiacausedbyhumoraleffectsandbonedamageindicatepooroutcomesinnewlydiagnosedmultiplemyelomapatients AT wangyutong hypercalcemiacausedbyhumoraleffectsandbonedamageindicatepooroutcomesinnewlydiagnosedmultiplemyelomapatients AT luminqiu hypercalcemiacausedbyhumoraleffectsandbonedamageindicatepooroutcomesinnewlydiagnosedmultiplemyelomapatients AT chubin hypercalcemiacausedbyhumoraleffectsandbonedamageindicatepooroutcomesinnewlydiagnosedmultiplemyelomapatients AT shilei hypercalcemiacausedbyhumoraleffectsandbonedamageindicatepooroutcomesinnewlydiagnosedmultiplemyelomapatients AT gaoshan hypercalcemiacausedbyhumoraleffectsandbonedamageindicatepooroutcomesinnewlydiagnosedmultiplemyelomapatients AT fanglijuan hypercalcemiacausedbyhumoraleffectsandbonedamageindicatepooroutcomesinnewlydiagnosedmultiplemyelomapatients AT xiangqiuqing hypercalcemiacausedbyhumoraleffectsandbonedamageindicatepooroutcomesinnewlydiagnosedmultiplemyelomapatients |